Susquehanna International Group’s Carisma Therapeutics CARM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-73,323
Closed -$111K 12089
2024
Q2
$111K Buy
+73,323
New +$109K ﹤0.01% 10945
2024
Q1
Sell
-10,062
Closed -$29.5K 12275
2023
Q4
$29.5K Buy
+10,062
New +$29.9K ﹤0.01% 11885
2023
Q3
Sell
-10,259
Closed -$64.9K 12093
2023
Q2
$90K Buy
+10,259
New +$55.9K ﹤0.01% 11028
2023
Q1
Sell
-21,722
Closed -$207K 12647
2022
Q4
$265K Buy
21,722
+1,266
+6% +$13.3K ﹤0.01% 9409
2022
Q3
$174K Buy
20,456
+5,781
+39% +$78.7K ﹤0.01% 11040
2022
Q2
$238K Buy
14,675
+5,567
+61% +$63.7K ﹤0.01% 10180
2022
Q1
$110K Sell
9,108
-23,020
-72% -$322K ﹤0.01% 11836
2021
Q4
$524K Sell
32,128
-2,681
-8% -$54K ﹤0.01% 9064
2021
Q3
$552K Sell
34,809
-4,244
-11% -$204K ﹤0.01% 9123
2021
Q2
$3.61M Sell
39,053
-349
-0.9% -$22.3K ﹤0.01% 4656
2021
Q1
$2.05M Buy
39,402
+25,397
+181% +$1.2M ﹤0.01% 5853
2020
Q4
$378K Buy
+14,005
New +$355K ﹤0.01% 8836
2020
Q3
Sell
-3,318
Closed -$66.4K 10595
2020
Q2
$48K Sell
3,318
-33,304
-91% -$449K ﹤0.01% 9759
2020
Q1
$411K Buy
36,622
+4,335
+13% +$71K ﹤0.01% 7348
2019
Q4
$672K Buy
32,287
+18,993
+143% +$436K ﹤0.01% 6341
2019
Q3
$311K Buy
13,294
+7,880
+146% +$184K ﹤0.01% 8226
2019
Q2
$162K Buy
5,414
+3,399
+169% +$102K ﹤0.01% 9309
2019
Q1
$42K Buy
+2,015
New +$34.8K ﹤0.01% 8496
2018
Q4
Sell
-4,214
Closed -$181K 9090
2018
Q3
$181K Buy
4,214
+1,639
+64% +$63.9K ﹤0.01% 8295
2018
Q2
$100K Buy
2,575
+1,830
+246% +$80.6K ﹤0.01% 9042
2018
Q1
$16K Buy
+745
New +$14.3K ﹤0.01% 9145
2017
Q2
Hold
0
9286
2017
Q1
Sell
-779
Closed -$32.5K 9023
2016
Q4
$30K Sell
779
-1,048
-57% -$46.2K ﹤0.01% 9377
2016
Q3
$103K Buy
1,827
+494
+37% +$36.8K ﹤0.01% 7926
2016
Q2
$45K Buy
+1,333
New +$33.7K ﹤0.01% 8261
2016
Q1
Sell
-737
Closed -$44K 9050
2015
Q4
$44K Buy
+737
New +$41.8K ﹤0.01% 9123
2015
Q3
Sell
-1,981
Closed -$112K 9668
2015
Q2
$112K Buy
+1,981
New +$280K ﹤0.01% 9630

Other funds holding CARM